Terbinafine dosage and administration: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Terbinafine}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [...")
 
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}


==Dosage and Administration==
'''Fingernail [[onychomycosis]]'''
One 250 mg tablet once daily for 6 weeks.
'''Toenail [[onychomycosis]]'''
One 250 mg tablet once daily for 12 weeks.
The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600e2b3-65df-4fc3-8081-d574537d27e3 | publisher =  | date =  | accessdate =  }}</ref>
other FDA approved preparations
*CREAM;TOPICAL: 1%
*GRANULE;ORAL: EQ 125MG BASE/PACKET ; EQ 187.5MG BASE/PACKET
*TABLET;ORAL: EQ 250MG BASE


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600e2b3-65df-4fc3-8081-d574537d27e3 | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Revision as of 22:06, 7 January 2014

Terbinafine
LamISIL®,FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage and Administration

Fingernail onychomycosis One 250 mg tablet once daily for 6 weeks.

Toenail onychomycosis One 250 mg tablet once daily for 12 weeks.

The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.[1]

other FDA approved preparations

  • CREAM;TOPICAL: 1%
  • GRANULE;ORAL: EQ 125MG BASE/PACKET ; EQ 187.5MG BASE/PACKET
  • TABLET;ORAL: EQ 250MG BASE


References

  1. "TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED]".

Adapted from the FDA Package Insert.